Health News Review
  • Mar 25 2015

    A call to ban advertising testosterone for anti-aging

    The Journal of the American Geriatrics Society published an editorial, “Disease Mongering of Age-Associated Declines in Testosterone and Growth Hormone Levels.”  It’s written by Dr. Thomas Perls, Professor of Medicine and Geriatrics, Boston Medical Center and Dr. David Handelsman of the University of Sydney. Because we want to devote more attention to health care advertising [...]

    2 Comments
  • Mar 25 2015

    CBS: slow down the Alzheimer’s drug trial hype – 2 examples in 1 week.

    What follows are the third and fourth Alzheimer’s disease news items we’ve reviewed in the last 3 days.  This could be a full-time beat. Perhaps some of what we’re seeing was prompted by The Alzheimer’s Association conducting its “advocacy forum” in Washington this week, with a national fundraising dinner last night (with CNN’s Wolf Blitzer [...]

    1 Comment
  • Mar 24 2015

    Some journalists fire another “silver bullet” at Alzheimer’s amyloid target

    The following is a guest blog post from one of our regular contributors, Alan Cassels, who is an author, journalist, and drug policy researcher with an interest in how clinical research and experience on pharmaceuticals gets translated for policy-makers, prescribers and consumers. ————————– A March 20th story in the Boston Globe. “Biogen drug offers hope for [...]

    3 Comments
  • Mar 23 2015

    Sponsored journalist training on “precision medicine”: Zeroing in on a conflict of interest

    The following is a guest post from Andrew Holtz, one of our longtime contributors, my former colleague at CNN, and a past president of the Association of Health Care Journalists.  This is at least the sixth time that we have addressed National Press Foundation workshop funding on this site. ———————— The question came from multiple [...]

    2 Comments
  • Mar 23 2015

    Questions for TIME about its prediction of a pill to make us more compassionate

    I was challenged by a fellow health care journalist to address a story by TIME.com, with this headline, “There Could Soon Be a Pill to Make Us More Compassionate.” The story reports that, in “a new study, published in the journal Current Biology…A group led by researchers at University of California Berkeley and University of California [...]

    No Comments
  • Mar 19 2015

    Nick Bilton blames readers for not knowing who Joseph Mercola is

    The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.  The New York Times public editor Margaret Sullivan has an excellent post up about the fear-mongering cancer story that I wrote about yesterday. She acknowledges that the coverage on this story was lacking in many ways. She also notes that Nick Bilton [...]

    5 Comments
  • Mar 18 2015

    Why is the New York Times turning to Joseph Mercola as an expert on cancer risk?

    The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.  Alert reader Bahar Gholipour (@Alterwired on Twitter) pointed us to a story appearing in today’s New York Times Style section about the potential cancer risks posed by wearable technology such as the new Apple Watch. With Gary out of the office [...]

    5 Comments
  • Mar 18 2015

    Dissecting press release puffery – Trudy Lieberman guest post

    The following is a guest post by our blog contributor, Trudy Lieberman. The longer she’s been covering health care issues, the more tuned-in she seems to be about claims she sees in health care public relations. ————————— Back in 2002 Dartmouth researchers Steve Woloshin and Lisa Schwartz concluded in JAMA that press releases from medical journals [...]

    8 Comments
  • Mar 17 2015

    The headline I wish I’d seen about the new PCSK9 cholesterol drugs

    The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.    “New Drugs Cut Heart Risks by One Percentage Point: Study” That’s the headline I didn’t see from any stories yesterday about two new cholesterol drug studies presented at the American College of Cardiology meeting. While it might sound like something [...]

    5 Comments
  • Mar 16 2015

    Water fluoridation and ADHD: Newsweek wades into the quagmire

    The following is a guest blog post by Alan Cassels, a pharmaceutical policy researcher at the University of Victoria and the author of Seeking Sickness: Medical Screening and the Misguided Hunt for Disease (Greystone, 2012). The opinions are his; you are welcome to your own. No randomized trial has ever been done to prove if adding [...]

    28 Comments